Posts
Eli Lilly hikes 2025 outlook, tops quarterly estimates...
Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped...
Eli Lilly shares drop after obesity pill shows modest late-stage...
Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free...
Doximity buys Pathway Medical for $63 million to help doctors...
Pathway's AI-powered clinical reference tool helps doctors answer questions about...
Omada Health beats on revenue in first earnings report...
The company offers virtual care programs to support patients with chronic conditions.
CNBC Daily Open: Of markets, tariffs and TACO
These might be the highest tariffs the world has seen since the Smoot-Hawley Act...
Investing in Space: Space IPOs are rearing their heads...
A recent string of IPOs signals the space sector is once more warming to traditional...
South Korea launches national AI model in tech race with...
South Korea is looking to create a near self-sufficient AI industry and position...
SoftBank Group pares earlier gains to rise over 10%, hitting...
The company hit an intra-day record high of 14,390.
Trump's ‘100% chip tariffs’ hit Japan's giants, but Samsung...
Asia chip stocks fell on Thursday after U.S. President Donald Trump announced he...
China's July exports top expectations, rising over 7%;...
Exports climbed 7.2% in July in U.S. dollar terms from a year earlier, exceeding...
